Prostatic Neoplasms: all 6,484 studies
Page 36 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Expanded Access 68Gallium-PSMA-11 PET for Prostate CancerApproved for marketingNCT04377152
- A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local AnesthesiaCompletedNCT04376008Not applicable
- A Clinical Trial of AdNRGM Plus CB1954 in Prostate CancerCompletedNCT04374240Phase 1
- PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent BrachytherapyStatus unknownNCT04369508
- Quality of Life in Prostate Cancer PatientsActive, not recruitingNCT04357925
- ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy SettingTerminatedNCT04357717
- Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate CancerStatus unknownNCT04356430Phase 2
- Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)Active, not recruitingNCT04349501Not applicable
- Expanded Access Protocol of 68Ga-PSMA-11 for PET ImagingApproved for marketingNCT04348682
- Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate CancerSuspendedNCT04346225Phase 2
- Effect of ADT in Chinese Male With Prostate CancerCompletedNCT04341324
- 18F-fluorocholine and 18F-fluoride PET in Prostate CancerCompletedNCT04340765Not applicable
- The Effect of Information Support Program on Self-efficacy of Prostate Cancer Patients During Hormonal TherapyCompletedNCT04340713Not applicable
- Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-ProgressorsActive, not recruitingNCT04340245
- Spermine Measuring Device Evaluation ProtocolWithdrawnNCT04339920
- Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)CompletedNCT04332744Phase 2
- The Genomic Medicine at VA StudyActive, not recruitingNCT04331535Not applicable
- Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate CancersCompletedNCT04330716Not applicable
- Identification of Predictive BiomarkersCompletedNCT04324983Not applicable
- Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer ScreeningStatus unknownNCT04322045Not applicable
- Influence of Prostate Cancer Radiation on AgingCompletedNCT04321187
- MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate CancerStatus unknownNCT04320147Not applicable
- Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMAActive, not recruitingNCT04319783Phase 2
- Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate CancerActive, not recruitingNCT04319146Not applicable
- An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate CancerCompletedNCT04318028Not applicable
- Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mLStatus unknownNCT04317625Not applicable
- National Cancer Institute "Cancer Moonshot Biobank"Active, not recruitingNCT04314401
- Using Meditation for Oncology AnxietyWithdrawnNCT04312191Not applicable
- Evaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPYCompletedNCT04307056Not applicable
- Focal Laser Ablation of Prostate CancerCompletedNCT04305925Early Phase 1
- Tailored, wEb-based, Psychosocial and Physical Activity Self-Management PrOgrammeCompletedNCT04304196Not applicable
- A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted SurgeryWithdrawnNCT04304079Not applicable
- Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapyActive, not recruitingNCT04302454Phase 3
- Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate CancerCompletedNCT04301414Early Phase 1
- Clinical Trial of Green Tea Catechins in Men on Active SurveillanceActive, not recruitingNCT04300855Phase 2
- Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer PatientsStatus unknownNCT04300673Phase 1/2
- Evaluation of the PI-RADS v2.1 Score Using Multiple ReadersCompletedNCT04299997
- Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical ProstatectomyActive, not recruitingNCT04299620Not applicable
- PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical TreatmentCompletedNCT04298112
- 177Lu-PSMA-I&T Prior to Radical Prostatectomy for Locally Advanced DiseaseStatus unknownNCT04297410Not applicable
- Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on AbirateroneWithdrawnNCT04296578Phase 1
- Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical ProstatectomyActive, not recruitingNCT04295447Phase 2
- pCHIP: Prostate Cancer Health Impact ProgramTerminatedNCT04293406
- Fasting Mimicking Diet in Prostate Cancer and Metabolic SyndromeStatus unknownNCT04292041
- Comparison of Prostate Fusion Biopsies With Software and CognitiveStatus unknownNCT04291742Not applicable
- PK and Dose Escalation and Expansion Study of DST-2970TerminatedNCT04291664Phase 1
- Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical ProstatectomyWithdrawnNCT04288336Early Phase 1
- Educational Program Plus Physiotherapy After ProstatectomyStatus unknownNCT04284020Not applicable
- Impact of Magnetic Resonance and Biomarkers for Screening for Prostate Cancer. Cost-effectiveness AnalysisStatus unknownNCT04283032
- Streaming Web-based Exercise At Home: A Pilot StudyCompletedNCT04282967Early Phase 1
- Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate CancerCompletedNCT04282824Early Phase 1
- Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the BodyCompletedNCT04281147
- Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate CancerTerminatedNCT04279561Phase 1
- Fertility After Prostate BrachytherapyStatus unknownNCT04278443
- Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate CancerWithdrawnNCT04272645Phase 2
- Role of Lymphnode Dissection in Men With Prostate Cancer Treated With Radical ProstatectomyActive, not recruitingNCT04269512Not applicable
- A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With DiethylstilbestrolCompletedNCT04268628
- Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate CancerActive, not recruitingNCT04267887Phase 2
- EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer ProgressionCompletedNCT04266431Not applicable
- Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA LigandCompletedNCT04266392Early Phase 1
- High-Intensity Training for Men With Prostate Cancer on Active Surveillance: A Feasibility StudyTerminatedNCT04266262Not applicable
- AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord AllograftActive, not recruitingNCT04263025Phase 2/3
- Faecal Incontinence in Prostate Cancer Survivors Treated Whith RadiotherapyActive, not recruitingNCT04262609
- Ferumoxtran-10-enhanced MRI in Prostate Cancer PatientsTerminatedNCT04261777Phase 3
- Interactive Decision Aid for Men Diagnosed With Prostate CancerCompletedNCT04260737Not applicable
- Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
- PRECISE, a Study to Gather More Information About Bone Fractures and Survival in Castration-resistant PRostate Cancer (CRPC) patiEnts Treated With Radium-223 in Routine Clinical practIce in SwedEnCompletedNCT04256993
- Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate CancerActive, not recruitingNCT04253483Phase 2
- A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT04253262Phase 1/2
- Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPVStatus unknownNCT04251546
- P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)TerminatedNCT04249947Phase 1
- Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer PatientsStatus unknownNCT04248621Phase 4
- Immune Profiling After HDR in Local Relapsed Prostate CancerCompletedNCT04247217
- 5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:Status unknownNCT04245670Not applicable
- PSMA-PET/MRI Low- and Intermediate-Risk Prostate CancerWithdrawnNCT04243941Phase 2
- Biopsy Collection for Men Undergoing Brachytherapy for Prostate CancerWithdrawnNCT04243473
- An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate TissueActive, not recruitingNCT04240639Not applicable
- Marker Driven Selection of Patients for Prostate Biopsy and ManagementActive, not recruitingNCT04240327
- F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate CancerStatus unknownNCT04239742Not applicable
- Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate CancerStatus unknownNCT04239599Not applicable
- Stereotactic Pelvic Brachytherapy With HDR Boost for Dose Escalation in High Tier Intermediate and High Risk Prostate caStatus unknownNCT04236752Not applicable
- Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomyTerminatedNCT04234399
- Study to Gather Information on the Safety and How Radium-223 Dichloride, an Alpha Particle-emitting Radioactive Agent, Works Under Routine Clinical Practice in Taiwan in Patients With Castration-resistant Prostate Cancer (CRPC) Which Has Spread to the BoneCompletedNCT04232761
- Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2)Status unknownNCT04228055Not applicable
- A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate CancerTerminatedNCT04227275Phase 1
- Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate CancerStatus unknownNCT04225910Early Phase 1
- Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate CancerWithdrawnNCT04225299Phase 3
- Metastasis-directed Therapy in Castration-refractory Prostate CancerActive, not recruitingNCT04222634Not applicable
- An Intimacy Intervention for Couples Completing Breast or Prostate CancerCompletedNCT04221607Not applicable
- Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate CancerStatus unknownNCT04220398Not applicable
- MR Radiomic Features in Prostate CancerCompletedNCT04219059
- Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African AmericansActive, not recruitingNCT04215029Not applicable
- Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate CancerActive, not recruitingNCT04197141Phase 2
- A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate CancerActive, not recruitingNCT04194554Phase 1/2
- Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPCCompletedNCT04193657
- Efficacy and Safety Assessment of IRE of Localized Prostate CancerStatus unknownNCT04192890Not applicable
- Deep Learning for Prostate SegmentationStatus unknownNCT04191980
- Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their PartnersActive, not recruitingNCT04189770
- 177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate CancerStatus unknownNCT04188587Phase 2
- CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITIONStatus unknownNCT04188275